Indraprastha Apollo Hospitals Pioneers Robotic Cardiac Surgery
The robotic surgery market is projected to grow from USD 8 billion to USD 25.4 billion by 2030
Indraprastha Apollo Hospitals in New Delhi announced on Saturday the success of its robotic cardiac surgery program. At a press conference led by eminent cardiac surgeons MM Yusuf and Varun Bansal, the hospital showcased the benefits and growing adoption of robotic heart surgery and robotic coronary artery bypass grafting (CABG).
The robotic surgery market is projected to grow from USD 8 billion to USD 25.4 billion by 2030. With a 98 per cent success rate, Indraprastha Apollo Hospitals has positioned itself as a leader in robotic cardiac surgery, the experts highlighted. This minimally invasive approach uses advanced robotic technology to perform procedures through very small incisions, offering significant advantages over traditional open-heart surgery. Benefits include the use of all arterial grafts, fewer complications, no bone cutting, shorter recovery times, and minimal scarring.
MM Yusuf, Senior Consultant and Heart Specialist in Robotics and Minimally Invasive Heart Surgery, highlighted the transformative impact of robotic surgery and said, “Robotic cardiac surgery signifies a revolutionary advancement in heart care. By leveraging cutting-edge robotic technology, we are able to perform highly precise and minimally invasive procedures that significantly reduce recovery times and postoperative complications. Patients benefit from quicker mobilisation, reduced scarring, and a faster return to normal life.”
Varun Bansal, Consultant Heart Specialist in Robotics and Minimally Invasive Heart Surgery, echoed these sentiments stating,“Robotic and minimally invasive cardiac surgeries represent a significant leap forward in cardiac care. By integrating advanced technology with surgical expertise, we offer our patients fewer complications, faster recoveries, and a better overall quality of life. This approach reduces the physical, emotional, and financial burden on patients and their families.”
The conference emphasised the numerous benefits of these advanced techniques for patients of all ages. Patients often begin walking within a day of surgery and are discharged within 48-72 hours. Robotic heart surgeries are especially beneficial for those with coronary artery disease, heart valve diseases, heart tumours, and congenital heart defects.
Case studies presented by Yusuf and Bansal showcased the hospital’s expertise in managing complex conditions with robotic assistance. Stories included high-risk patients for open-heart surgery and those needing a quick return to work. These patients experienced swift recoveries and resumed their lives quickly, highlighting the effectiveness of robotic cardiac surgeries.
